Drugmakers Aim to Curb Antibiotic Waste That Adds to Resistance

June 14, 2022, 12:00 PM UTC

A coalition of drugmakers is introducing new standards aimed at curbing the release of antibiotic waste into the environment amid growing concerns over drug resistance that’s been linked to more than a million annual deaths globally.

The guidelines will help ensure antibiotics are made responsibly, minimizing environmental risks, the AMR Industry Alliance said Tuesday in a statement. The group also plans to launch a certification program next spring that will allow manufacturers to show requirements have been met through independent evaluation, initially by UK-based BSI Standards Limited.

Overuse and overexposure to antibiotics helps breed resistant bacterial strains that can ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.